Navigation Links
Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
Date:6/18/2008

LOS ANGELES, California, June 18 /PRNewswire-FirstCall/ -- Canopus BioPharma, Inc. (OTC: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer and addiction, today announced the signing of a licensing agreement with the Wisconsin Alumni Research Foundation (WARF), an organization serving the University of Wisconsin-Madison scientific community by patenting the discoveries of UW-Madison researchers and licensing these technologies to leading companies in Wisconsin, the United States and worldwide. The agreement provides comprehensive licensing rights and patent protection relating to Canopus' Phase II oncology drug candidate, CB1400.

"Securing the rights to the WARF patents strengthens Canopus BioPharma's intellectual property position for future licensing opportunities of CB1400, one of our most exciting products," said Patrick Prendergast, Chairman and Chief Executive Officer of Canopus BioPharma. "In the near future, we expect to announce important results from our studies using CB1400, which will further validate the potential significance of our drug for oncology and related indications."

Canopus BioPharma expects to develop CB1400 as a method for preventing and reducing mucositis (lesions in the gastrointestinal and oral mucosa caused by chemo- and/or radiotherapy). The domestic market alone for a preventative anti-mucositis agent is estimated to be over $1 billion per annum. The compound underlying CB1400 had been previously developed and patented by a major pharmaceutical company as an anti-parasitic agent. Canopus discovered that this approved drug was highly effective for an alternative indication, specifically for use in preventing mucositis. Canopus BioPharma's market opportunity with CB1400 includes various applications associated with cancer therapy and cancer treatment side effects.

CB1400, a former anti-schistosomal drug
'/>"/>

SOURCE Canopus BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... China South 2015 came to a successful conclusion on April ... South has been recognized by industry insiders through its professional ... the medical device manufacturing industry in Southern China ... the successful return of the MEDTEC brand to Shenzhen ... in 2005. , The ...
(Date:6/3/2015)... Genoa has received ... two pharmacy organizations with proven track records for excellent ... strong reputations for outstanding customer service, flexibility and delivering ... Genoa is the leading provider of pharmacy ... affiliated with managing the cost and quality of their ...
(Date:6/3/2015)... , June 02, 2015 Research and ... the "Global Pharmaceutical Packaging Market 2015-2019" report ... market to grow at a CAGR of 5.9% over ... witnessed in the market is the rise in demand ... slated for the second highest growth among all the ...
Breaking Medicine Technology:MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2Global Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, Gerresheimer, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2
... CHAPEL HILL, N.C., April 10, 2012  TSI Healthcare ... practices had attested to successfully meeting "Meaningful Use" ... Records (EHR) Systems. These providers completed data collection ... 1 reporting period for the Federal Government sponsored ...
... CreatiVasc Medical has been selected as one of ... Innovation Pathway program that uses collaboration with innovators ... safeguarding patient safety. The company has ... the Hemoaccess Valve System®, which has the potential ...
Cached Medicine Technology:TSI Healthcare Customers Receive Government Incentives for Meeting EHR Requirements 2FDA Selects CreatiVasc For New Innovation Pathway Program 2
(Date:6/3/2015)... Wallingford, CT (PRWEB) June 03, 2015 ... devices, announces today since June has been designated as ... Company commends the Tucson, AZ. Police Department for its ... that its personnel utilized their Individual First Aid Kits ... help civilians involved in shootings, stabbings or traffic accidents. ...
(Date:6/3/2015)... 03, 2015 Sitting at a computer ... in the back, neck, shoulders and/or wrists. This can ... In addition, recent research links sitting for long periods ... diseases. Fortunately, three inventors from Oakville, Ontario, are offering ... desk. , They have developed a prototype for a ...
(Date:6/3/2015)... June 03, 2015 Implant design can ... osseointegration processes that unites bone to an implant surface. ... has been designed to encourage bone regeneration, resulting in ... of stable surrounding soft tissues for more esthetic restorations. ... Product Manager at MIS Implants. The triangular neck of ...
(Date:6/3/2015)... ON (PRWEB) June 03, 2015 On ... a Marketing Authorization (MA), effective immediately, which now permits ... foods that contain oats as ingredients. The MA is ... being developed. All stakeholders should be aware that, unlike ... in the USA, there are restrictions for gluten-free oat ...
(Date:6/3/2015)... Unfortunately, a majority of shoes sold are not up to ... users throughout the year. Be it a pair of shoes ... the makers generally tend to put all of their focus ... and health. To counter this problem and provide a solution ... Technologies have come up with uGALE, an insole that not ...
Breaking Medicine News(10 mins):Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3
... control for people with type 2 diabetes who have not ... taken in addition to the baseline insulin administered throughout the ... body of published research. br>,People who use insulin to ... insulin at mealtimes to regulate the glucose response to food. ...
... BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced ... (sorafenib) tablets has been submitted to the U.S. ... patients with hepatocellular carcinoma (HCC), the most common form ... in more than 50 countries for the treatment of ...
... a bacterium that causes deadly Hib pneumonia and meningitis, ... ,A new study from Bangladesh published ... showed that routine immunization of infants with a Hib ... and approximately 90% of Hib meningitis cases. A similar ...
... pipes to smoke tobacco are waging an 11th-hour bid for ... in England on Sunday. ,Without the shisha, ... dozens of restaurants will lose their main appeal to tourists, ... ,"It's a disaster, we don't know what to do ...
... 105-year-old exile who was detained for 30 years in his native ... citizen at a ceremony in Miami. ,Now, he ... ,And the former fisherman is convinced he will outlive the ... ,"He's far less healthy than I am, he can hardly ...
... wife's baby after doctors refused to touch the HIV-positive woman, ... India's NDTV news channel he carried out the delivery as ... state of Uttar Pradesh shouted instructions from a distance. ... asked me to pull out the baby and cut the ...
Cached Medicine News:Health News:Inhaled Insulin for Type 2 Diabetes Shows Mixed Results 2Health News:Inhaled Insulin for Type 2 Diabetes Shows Mixed Results 3Health News:Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer 2Health News:Hib Vaccination can Prevent Pneumonia 2Health News:Hib Vaccination can Prevent Pneumonia 3Health News:Shisha Owners Mobilise Against July 1 Smoking Ban in England 2Health News:Shisha Owners Mobilise Against July 1 Smoking Ban in England 3Health News:The American Dream Comes True for 105-year-old Cuban 2Health News:Indian Doctors Refuse to Help HIV-positive Woman Deliver: Report 2
A major advancement in the management of Pelvic Fracture Care, permitting rapid stabilization and surgical access....
The large External Fixator consists of rods, clamps, and pins. It has multiple external fixation frames, independent pin placement, and MR safe clamps. The modular frame construction permits fracture...
The Pinless Fixator can be applied quickly and easily in the OR or ER to stabilize the fracture and soft tissues without invading the medullary canal, minimizing the risk of infection associated with...
... The Hoffmann® II Compact™ Upper extremity ... anatomy of the distal radius by allowing ... planes. One of the main goals has ... while providing total versatility and ease of ...
Medicine Products: